ARAmanda Robison

Amanda Robison

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amanda Robison has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure

    by Emma K. Loveday, Kyle S. Hain, Irina Kochetkova, Jodi F. Hedges, Amanda Robison, Deann T. Snyder, Susan K. Brumfield, Mark J. Young, Mark A. Jutila, Connie B. Chang, et al.

    The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study, we validated and compared two protocols for inactivating SARS-CoV-2: heat treatment and ultraviolet irradiation. The two methods were optimized to render the virus completely incapable of infection while limiting the destructive effects of inactivation. We observed that 15 min of incubation at 65 °C completely inactivates high titer viral stocks. Complete inactivation was also achieved with minimal amounts of UV power (70,000 µJ/cm2), which is 100-fold less power than comparable studies. Once validated, the two methods were then compared for viral RNA quantification, virion purification, and antibody detection assays. We observed that UV irradiation resulted in a 2-log reduction of detectable genomes compared to heat inactivation. Protein yield following virion enrichment was equivalent for all inactivation conditions, but the quality of resulting viral proteins and virions were differentially impacted depending on inactivation method and time. Here, we outline the strengths and weaknesses of each method so that investigators might choose the one which best meets their research goals.


  • Roles of Toll-Like Receptor 2 (TLR2), TLR4, and MyD88 during Pulmonary Coxiella burnetii Infection

    by Andrew G. Ramstead, Amanda Robison, Anne Blackwell, Maria Jerome, Brett Freedman, Kirk J. Lubick, Jodi F. Hedges, Mark A. Jutila

    Coxiella burnetii, the causative agent of Q fever, is an obligate intracellular primarily pulmonary bacterial pathogen. Though much is known about adaptive immune responses against this bacterium, our understanding of innate immune responses against C. burnetii are not well defined, particularly within the target tissue for infection - the lung. Previous studies examined the roles of the innate immune system receptors, TLR2 and TLR4, in peripheral infection models and described minimal phenotypes in specific gene deletion animals compared to their wildtype controls. Here, we assessed the roles for TLR2, TLR4, and MyD88 in pulmonary C. burnetii infection and compared responses to those that occurred in TLR2 and TLR4 deficient animals following peripheral infection. As observed previously, neither TLR2 nor TLR4 were needed for limiting bacterial growth after peripheral infection. In contrast, TLR2 and to a lesser extent TLR4 limited growth (or dissemination) of the bacterium in the lung and spleen after pulmonary infection. TLR2, TLR4, or MyD88 were not required for the general inflammatory response in the lungs after pulmonary infection. However, MyD88 signaling was important for infection-induced morbidity. Finally, TLR2 expression on hematopoietic cells was most important for limiting bacterial growth in the lung. These results expand on our knowledge of the roles for TLR2 and TLR4 in C. burnetii infection and suggest varying roles for these receptors that are dictated by the site of infection.